Cytek Biosciences to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Cytek Biosciences (Nasdaq: CTKB) announced participation in three upcoming healthcare investor conferences in September 2026. The company will attend the Wells Fargo 21st Annual Healthcare Conference on September 8, the Morgan Stanley 24th Annual Global Healthcare Conference with a fireside chat on September 16, and Deutsche Bank’s 2026 Healthcare Summit on September 17.

According to Cytek Biosciences, CEO Wenbin Jiang and CFO William McCombe will join select sessions, and a live and archived webcast of the Morgan Stanley fireside chat will be available via the investors section of the company’s website.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FREMONT, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences.

• Wells Fargo 21^st Annual Healthcare Conference in Boston, MA
  CFO William McCombe will be participating in investor meetings on Tuesday, September 8, 2026

• Morgan Stanley 24^th Annual Global Healthcare Conference in New York, NY
  CEO Wenbin Jiang and CFO William McCombe will be participating in a fireside chat on Wednesday, September 16, 2026, at 9:15 a.m. Pacific Time / 12:15 p.m. Eastern Time

• Deutsche Bank’s 2026 Healthcare Summit in New York, NY
  CEO Wenbin Jiang and CFO William McCombe will be participating in investor meetings on Thursday, September 17, 2026

Interested parties may access the live and archived webcast for the Morgan Stanley event referenced above on the “Investors” section of the company website at: investors.cytekbio.com.

About Cytek Biosciences, Inc.

Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ (FSP®) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek’s platform includes: its core FSP instruments, the Cytek Aurora™, Northern Lights™, Cytek Aurora™ CS, Cytek Aurora™ Evo, and Cytek Borealis™ systems; the Cytek Orion™ reagent cocktail preparation system; the Enhanced Small Particle™ (ESP™) detection technology; the flow cytometers and imaging products under the Amnis® and Guava® brands; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is available at www.cytekbio.com.

Cytek’s products are for research use only and not for use in diagnostic procedures (other than Cytek’s Northern Lights-CLC system and certain reagents, which are available for clinical use only in China and the European Union).

Cytek, Full Spectrum Profiling, FSP, Cytek Aurora, Cytek Borealis, Northern Lights, Enhanced Small Particle, ESP, Cytek Orion, Amnis and Guava are trademarks of Cytek Biosciences, Inc.

In addition to filings with the Securities and Exchange Commission (SEC), press releases, public conference calls and webcasts, Cytek uses its website (www.cytekbio.com), LinkedIn page and X account as channels of distribution for information about the company, its products, planned financial and other announcements, attendance at upcoming investor and industry conferences and other matters. Certain information disseminated through these channels may be material to investors, and Cytek may use these channels to disseminate such information in accordance with Regulation FD and other applicable disclosure requirements. Therefore, investors should monitor Cytek’s website, LinkedIn page, and X account in addition to following its SEC filings, news releases, public conference calls and webcasts.

Media Contact:
Stephanie Olsen
Lages & Associates
(949) 453-8080
stephanie@lages.com

Investor Contact:
Mark Meehan
Cytek Biosciences
mmeehan@cytekbio.com

FAQ

What upcoming investor conferences will Cytek Biosciences (CTKB) attend in September 2026?

Cytek Biosciences will attend three healthcare investor events in September 2026. According to Cytek Biosciences, these are the Wells Fargo 21st Annual Healthcare Conference, the Morgan Stanley 24th Annual Global Healthcare Conference, and Deutsche Bank’s 2026 Healthcare Summit, all focused on healthcare investors.

When is Cytek Biosciences’ (CTKB) fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference?

Cytek Biosciences’ fireside chat is scheduled for September 16, 2026, at 9:15 a.m. Pacific / 12:15 p.m. Eastern. According to Cytek Biosciences, CEO Wenbin Jiang and CFO William McCombe will participate in this session at the Morgan Stanley Global Healthcare Conference.

How can investors access the Cytek Biosciences (CTKB) webcast from the Morgan Stanley 2026 healthcare conference?

Investors can access the live and archived webcast through the investors section of Cytek Biosciences’ website. According to Cytek Biosciences, the webcast for the Morgan Stanley event will be available at investors.cytekbio.com for those unable to attend in person.

Who from Cytek Biosciences (CTKB) will participate in the September 2026 investor conferences?

Cytek Biosciences’ CEO Wenbin Jiang and CFO William McCombe will participate in select conference events. According to Cytek Biosciences, McCombe will join investor meetings at Wells Fargo’s conference, while both executives will join a Morgan Stanley fireside chat and Deutsche Bank investor meetings.

What are the key dates for Cytek Biosciences’ (CTKB) September 2026 investor meetings?

Cytek Biosciences’ investor meetings occur on September 8, 16, and 17, 2026. According to Cytek Biosciences, these dates correspond to the Wells Fargo Healthcare Conference, Morgan Stanley Global Healthcare Conference fireside chat, and Deutsche Bank’s Healthcare Summit in New York.